Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10532036 | AFT PHARMS LTD | Combination composition |
Sep, 2025
(1 year, 5 months from now) | |
US11534407 | AFT PHARMS LTD | Pharmaceutical compostion containing acetominophen and ibuprofen |
Feb, 2039
(14 years from now) | |
US11197830 | AFT PHARMS LTD | Pharmaceutical composition containing acetaminophen and ibuprofen |
Feb, 2039
(14 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Product(NP) | Mar 01, 2026 |
Market Authorisation Date: 01 March, 2023
Treatment: A method of treating mild to moderate acute pain in adults by administering 975-1000 mg of acetaminophen and 292.5-300 mg of ibuprofen in a single administration
Dosage: TABLET;ORAL